KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Amortization of Deferred Charges: 2015-2019

Historic Amortization of Deferred Charges for Medpace Holdings (MEDP) over the last 4 years, with Sep 2019 value amounting to $80,000.

  • Medpace Holdings' Amortization of Deferred Charges fell 48.05% to $80,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $1.1 million, marking a year-over-year increase of 72.91%. This contributed to the annual value of $954,000 for FY2019, which is 55.12% up from last year.
  • According to the latest figures from Q3 2019, Medpace Holdings' Amortization of Deferred Charges is $80,000, which was down 89.13% from $736,000 recorded in Q2 2019.
  • In the past 5 years, Medpace Holdings' Amortization of Deferred Charges ranged from a high of $736,000 in Q2 2019 and a low of $80,000 during Q3 2019.
  • For the 3-year period, Medpace Holdings' Amortization of Deferred Charges averaged around $202,818, with its median value being $159,000 (2018).
  • As far as peak fluctuations go, Medpace Holdings' Amortization of Deferred Charges plummeted by 75.55% in 2017, and later spiked by 365.82% in 2019.
  • Medpace Holdings' Amortization of Deferred Charges (Quarterly) stood at $679,000 in 2015, then dropped by 18.70% to $552,000 in 2016, then plummeted by 70.29% to $164,000 in 2017, then decreased by 12.20% to $144,000 in 2018, then slumped by 48.05% to $80,000 in 2019.
  • Its Amortization of Deferred Charges was $80,000 in Q3 2019, compared to $736,000 in Q2 2019 and $138,000 in Q1 2019.